Snowball logo
logo
REKA

Rekah Pharmaceutical Industry Ltd

REKA β€’ TA
β‚ͺ10.66-β‚ͺ0.02Β  (0.19%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
263.9292.4321.7321.7301304.2
COGS
198.8213.7241.5249.8242.8236.9
Gross Profit
65.1678.780.271.9558.1767.29
Operating Expenses & Income
Operating Income
14.1413.252.95516.37(6.263)(7.391)
Total Operating Expenses
51.0265.4577.2555.5864.4374.68
R&D Expenses
2.0823.2323.7784.0744.3324.431
Selling General & Admin Expenses
6.4068.5430.6910.819.98733.98
Earnings from Continuing Operations
Interest Expense
(5.984)(6.475)(9.989)(6.709)(7.572)(7.326)
Interest Income
0.0660.0420.7140.3580.3740.558
Income Tax Expense
1.0962.4(0.138)1.7226.8766.297
Net Income
Net Income
6.624(2.043)(6.91)6.206(18.07)(18.54)
Supplemental
EBIT
12.9113.252.90614.64(4.784)(7.938)
EBITDA
35.7740.7326.0347.325.9922.27
In millions of ILS, except % and values per 1 share